04/19/23
04/19/23
Hypertension Guidelines Date
JNC
JNC 7 2003
JNC 8 2013
NICE Guidelines
NICE Guidelines 2011
ESC / ESH Hypertension Guidelines
ESC Guideline 2007
Reappraisal of 2007 Hypertension Guidelines
September 2009
04/19/23
The JNC 8 guidelines released towards the end of 2013, had several new things to offer
One highly discussed recommendation was that for patients aged 60 or above who don’t have DM and CKD, the target BP of 150/90 (instead of 140/90)…
The American society of hypertension and the European society for hypertension have stuck to the previous guidelines of 140/90.While BP of 150/90 may be acceptable, there is a consensus on evidence that with a target of 140/90 we are more sure about the reduction in risk of CVD and For patients between 18 to 59 years and those who not have DM and CKD,the target BP is 140/90.
04/19/23
1. Not evidence based recommendation
2. Recommendations by expert opinion only
3. Not unanimous, 5 members of the panel have disagreed
4. All societies have not accepted those recommendations
5. Some what controversial
04/19/23
04/19/23
04/19/23
04/19/23
SYMPLICITY HTN-3
SYMPLICITY HTN-4
Randomized Yes Yes
Controlled Yes Yes
Blinded Yes Yes
Number of subjects More than 500 More than 500
Number of Centers Participating
Up to 90 in the US Up to 100 in the US
Blood Pressure Required for Inclusion
> 160 mmHg Systolic
140-160 mmHg Systolic
04/19/23
1. Hypertension is the commonest clinical disorder and is a major health problem worldwide.
2. Inadequately controlled or uncontrolled hypertension leads to subclinical organ damage which can be progressive, leading to serious cardiovascular events like angina, MI and CHF, TIA and stroke, chronic renal failure, peripheral vascular disease and retinopathy.
3. Optimization of drug therapy with 1, 2 or 3 anti hypertensive agents in combination and /or full doses may be necessary .
4. Ambulatory and home B.P. monitoring should be encouraged
5. JNC 8 defined new target goals and has advised first line drugs and later line therapy.
6. Renal denervation therapy initially showed significant promise but in randomized blind trials with sham procedures, there was no significant difference in the B.P. levels upto 6 month in RDT vs control patients.
7. Some reports suggest benefit in uncontrolled hypertension with chronic renal failure.
8. Life style modification, reduced salt intake prevention of diabetes and obesity, cessation of smoking and use of appropriately tailored drug therapy can prevent end organ catastrophies.